The use of low molecular weight heparin (LMWH) involves a diverse group of health professionals and patients. There is an education requirement to support the safe use of LMWHs and to promote best practice.
This document aims to ensure that all patients receive appropriate anticoagulation in a timely manner and to address prescribers’ concerns relating to the safe prescribing of LMWH. It is intended to promote consistent advice to patients via efficient and consistent clinical pathways for the prescribing and supply of LMWH.
⇩ Prescribing of Low Moleculary Weight Heparin in Wales 313KB (PDF)